Washington Biotechnology, Inc. (WBI) is a leading In Vivo Services Contract Research Organization (CRO) for drug development.

For over 25 years we have provided our global biopharmaceutical clients with rapidly scheduled, accurate and cost-effective efficacy testing services.

Our clients drive innovation. We feel privileged to serve them in advancing treatments for human disease. In our role as CRO Partner, we are committed to the highest standards of science and project management.

WBI is focused on providing expert in vivo efficacy testing for a wide range of diseases:

• Autoimmune and Inflammatory Diseases
• Rheumatoid Arthritis
• Cancer
• Pain
• Bacterial Infection

To complement these disease models, WBI offers Pharmacokinetics and Toxicity testing in addition to a wide array of Support Services.